Search Results 1121-1130 of 19028 for Neutrophil

1. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) < 750 cells/mm^3 (0.75 x 10^9/L) unless there is documented bone marrow involvement; · Platelet count ...

2. A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

   Must have absolute neutrophil count ≥ 1.5 x 109/L within 14 days prior to randomization. Must have platelet count ≥ 100 x 109/L within 14 days prior to ...

3. Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

   Absolute neutrophil count ≥ 1,000/mm^3; Platelets ≥ 100,000/mm^3; Hemoglobin ≥ 10g/dL; Total serum bilirubin ≤ ULN; or total bilirubin ≤ 3.0 × ULN with ...

4. A Study Using Targeted Inhibitors to Treat Specific Tumor Mutations in Patients with Meningiomas - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1500/mm^3; Platelet Count ≥ 100,000/mm^3; Creatinine ≤ 1.5 mg/dl x upper limit of normal (ULN); Calc. Creatinine Clearance ...

5. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1,500/mm^3;; Platelet Count ≥ 75,000/mm^3;; Hemoglobin ≥ 10 g/dL;; Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum ...

6. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

   Hemoglobin \< 10 g/dL, absolute neutrophil count \< 1.2 × 103 per µL, platelet count \< 75,000 per µL, alanine aminotransferase and aspartate ...

7. Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) must be >= 1200/mm^3; Platelet count must be >= 100,000/mm^3; Hemoglobin must be >= 10 g/dL; Total bilirubin must be =< ULN ...

8. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/uL; Platelet ≥ 100,000/uL; Total bilirubin ≤ upper limit of normal (ULN) Aspartate aminotransferase (AST) (serum ...

9. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   ANC ≥ 1,500/mm³ (includes neutrophils and bands); Platelet count ≥ 100,000/mm³; Creatinine ≤ 2.0 mg/dL; AST and ALT ≤ 5 x upper limit of normal (ULN) ...

10. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin > 9.0 g/dL; Total serum bilirubin ≤ 2 mg/dL; Aspartate transaminase ...